Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 27, 2017 10:00 ET | Source: Apexian Pharmaceuticals

National Cancer Institute selects Apexian Pharmaceuticals to participate in the Small Business Innovation Research (SBIR) Initiative program

Indianapolis, Indiana, USA, Sept. 27, 2017 (GLOBE NEWSWIRE) --...
July 13, 2017 08:00 ET | Source: Apexian Pharmaceuticals

Apexian Pharmaceuticals Announces FDA Agreement For Inclusion of Chemotherapy Induced Peripheral Neuropathy (CIPN) Indication Under Currently Approved IND

INDIANAPOLIS, IN --(Marketwired - July 13, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company developing novel compounds to treat cancer, today announced that it has received FDA...
June 05, 2017 10:00 ET | Source: Apexian Pharmaceuticals

Early-stage clinical oncology company, Apexian Pharmaceuticals, licenses IU discoveries

INDIANAPOLIS, IN--(Marketwired - June 05, 2017) - Apexian Pharmaceuticals Inc., a biotechnology company focused on developing novel compounds to treat cancer, has licensed all technology discovered...
March 01, 2017 15:21 ET | Source: Apexian Pharmaceuticals

Apexian Pharmaceuticals Announces FDA Acceptance of Phase 1 Protocol to Include Biomarker Measurements and Evaluate the Tolerability and Anti-Tumor Effects of APX3330

INDIANAPOLIS, IN--(Marketwired - March 01, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company developing novel compounds to treat cancer, today announced that it has received FDA...
February 22, 2017 08:04 ET | Source: Apexian Pharmaceuticals

Apexian Pharmaceutical CEO, Steve Carchedi, to present at Drexel University's Guest Healthcare Lecture Series

PHILADELPHIA, PA--(Marketwired - February 22, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced that its...
February 03, 2017 16:28 ET | Source: Apexian Pharmaceuticals

Apexian Pharmaceutical CEO, Steve Carchedi, to present at BIO CEO and Investor Conference

INDIANAPOLIS, IN--(Marketwired - February 03, 2017) - Apexian Pharmaceuticals, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced that its...
October 31, 2016 08:00 ET | Source: Apexian Pharmaceutical, Inc

Apexian Pharmaceuticals Hires Richard Messmann, M.D. as Chief Medical Officer

INDIANAPOLIS, IN--(Marketwired - October 31, 2016) - Apexian Pharmaceutical, Inc., a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced the...
October 24, 2016 08:00 ET | Source: Apexian Pharmaceuticals, Inc.

ApeX Therapeutics Changes Name to Apexian Pharmaceuticals to Reflect Broader Advancement of Oncology Pipeline

INDIANAPOLIS, IN--(Marketwired - October 24, 2016) - ApeX Therapeutics, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced that it has...
October 10, 2016 08:00 ET | Source: ApeX Therapeutics, Inc.

ApeX Therapeutics Appoints Industry Veteran Steve Carchedi as CEO and Director

INDIANAPOLIS, IN--(Marketwired - October 10, 2016) - ApeX Therapeutics, a clinical stage biotechnology company focused on developing novel compounds to treat cancer, today announced the appointment of...
July 20, 2016 08:00 ET | Source: ApeX Therapeutics, Inc.

ApeX Therapeutics Announces FDA Acceptance of IND to Evaluate the Tolerability and Anti-Tumor Effects of APX3330

INDIANAPOLIS, IN--(Marketwired - July 20, 2016) - ApeX Therapeutics, a biotechnology company focused on developing novel compounds to treat cancer, today announced the acceptance of an Investigational...